Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

External validation of the ability of the DRAGON score to predict outcome after thrombolysis treatment

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Intracranial hemorrhage due to intracranial hypertension caused by the superior vena cava syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prevalence of family history in patients with reflex syncope

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Twiddler's syndrome in a patient with a deep brain stimulation device for generalized dystonia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Workforce Attachment after Ischemic Stroke – The Importance of Time to Thrombolytic Therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Age At Menopause: A Female Risk Factor of Stroke?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Easy-to-perform and valid assessment scales for the effect of thrombolysis are essential in hyperacute stroke settings. Because of this we performed an external validation of the DRAGON scale proposed by Strbian et al. in a Danish cohort. All patients treated with intravenous recombinant plasminogen activator between 2009 and 2011 were included. Upon admission all patients underwent physical and neurological examination using the National Institutes of Health Stroke Scale along with non-contrast CT scans and CT angiography. Patients were followed up through the Outpatient Clinic and their modified Rankin Scale (mRS) was assessed after 3 months. Three hundred and three patients were included in the analysis. The DRAGON scale proved to have a good discriminative ability for predicting highly unfavourable outcome (mRS 5-6) (area under the curve-receiver operating characteristic [AUC-ROC]: 0.89; 95% confidence interval [CI] 0.81-0.96; p
OriginalsprogEngelsk
TidsskriftJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Vol/bind20
Udgave nummer11
Sider (fra-til)1635-6
Antal sider2
DOI
StatusUdgivet - nov. 2013

ID: 43083752